|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1991-5-23
|
|
pubmed:abstractText |
Twenty-one patients with anorexia nervosa and 35 normal-weight patients with bulimia underwent a series of CSF studies involving measurement of CSF dynorphin A 1-8 immunoreactivity during hospitalization in an eating-disorder treatment and research program. The control group consisted of 17 healthy volunteers. There were no statistically significant differences in CSF dynorphin A 1-8 measurements among groups or within a group at various stages of treatment. These results regarding dynorphin A 1-8 immunoreactivity are discussed in light of other evidence for altered opiate function in some eating-disorder patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0006-3223
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
244-52
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1673064-Adult,
pubmed-meshheading:1673064-Anorexia Nervosa,
pubmed-meshheading:1673064-Body Weight,
pubmed-meshheading:1673064-Brain,
pubmed-meshheading:1673064-Bulimia,
pubmed-meshheading:1673064-Dynorphins,
pubmed-meshheading:1673064-Endorphins,
pubmed-meshheading:1673064-Female,
pubmed-meshheading:1673064-Humans,
pubmed-meshheading:1673064-Peptide Fragments,
pubmed-meshheading:1673064-Psychiatric Status Rating Scales,
pubmed-meshheading:1673064-Receptors, Opioid
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia.
|
|
pubmed:affiliation |
Department of Psychiatry, Harris County Psychiatric Center, Houston, TX 77021.
|
|
pubmed:publicationType |
Journal Article
|
